Epstein-Barr Virus and Its Role in NBD: Human Study Findings
A study found that 71.43% of treatment-naïve patients with neuro-Behçet's disease (NBD) had Epstein-Barr virus (EBV) DNA in their cerebrospinal fluid, compared to 35.29% in multiple sclerosis (MS). It also noted that EBV presence wasn't linked to a specific immune response, suggesting it may persist in a latent state. Elevated levels of certain cytokines were found in EBV-positive patients from NBD, indicating a different immune response compared to those with MS.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not demonstrated in people
- Mechanism
- EBV
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
The high prevalence of EBV in NBD versus MS highlights the potential role of this virus in influencing the disease's clinical manifestations. These findings could inform future research into how EBV might contribute to neuroinflammatory conditions and help distinguish different disease phenotypes.
What this does not prove
The study did not establish a clear mechanism behind the higher prevalence of EBV in NBD compared to MS, leaving a gap in understanding how EBV influences these diseases.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- No
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-08
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- treatment-naïve patients with NBD and MS
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceEpstein-Barr virus shapes intrathecal Th1/Th17 immunity and parenchymal involvement in neuro-Behçet's disease. ↗DOI: 10.3389/fimmu.2026.1921667
Supporting passages (12)
subjectsHuman
speciesHuman
sample size basistreatment-naïve patients with NBD and MS
randomizedNo
publication date2026-10-08
findingsRESULTS: In this study, we demonstrate a high prevalence of EBV DNA in the cerebrospinal fluid (CSF) of patients with NBD (71.43%), significantly higher than that observed in MS (35.29%), whereas other neurotropic herpesviruses are rarely detected.
mechanismsEBV
populationtreatment-naïve patients with NBD and MS
human efficacyNo
limitationsTitle: Epstein-Barr virus shapes intrathecal Th1/Th17 immunity and parenchymal involvement in neuro-Behçet's disease.
peer reviewedPublication types: Journal Article
subjectsMeSH terms: Humans; Herpesvirus 4, Human; Female; Adult; Male; Th1 Cells; Behcet Syndrome; Epstein-Barr Virus Infections; Middle Aged; Th17 Cells; DNA, Viral; Antibodies, Viral; Cytokines; Antigens, Viral; Virus Latency; Multiple Sclerosis
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.